The study prioritized variants for ARDS susceptibility, severity, and 60-day mortality at ARSD, XKR3, and ZNF335 genes, which were validated in another small cohort of ARDS cases (N = 117). The gene discussed is XKR3; the disease is acute respiratory distress syndrome.